Doctors Note Logo

Published on: 8/18/2026

Can Bisphosphonates Cause Thigh Bone Fractures?

Yes, bisphosphonates can cause an unusual type of thigh bone break called an atypical femoral fracture, though this risk is very rare and far outweighed by the medication's proven benefit in preventing common osteoporotic fractures. These breaks occur in the outer thigh bone below the hip and are linked to long-term use, typically beyond three to five years, with risk rising the longer treatment continues. Warning signs often appear weeks or months in advance as a dull, aching pain in the groin, hip, or thigh that worsens with activity, and reporting this pain early allows for imaging before a complete break happens. Doctors may recommend a "drug holiday" after several years of treatment for people at lower risk, while those at high fracture risk often continue therapy because stopping raises the chance of hip and spine fractures. Several important factors affect your individual risk, including treatment duration, bone health, and other medications, so see below to understand more.

Last reviewed for medical accuracy: 08/18/2026

If you are experiencing thigh, hip, or groin pain and are unsure what it means, a free, instant symptom check can help you organize your symptoms and understand which next steps make sense. It takes only a few minutes, requires no sign-up, and gives you clearer language to bring to your doctor so nothing important gets overlooked. Early reporting of unexplained thigh pain is one of the few things known to prevent a partial stress fracture from becoming a complete break, which makes acting now genuinely worthwhile.Yes, bisphosphonates can cause an unusual type of thigh bone break called an atypical femoral fracture, though this risk is very rare and far outweighed by the medication's proven benefit in preventing common osteoporotic fractures. These breaks occur in the outer thigh bone below the hip and are linked to long-term use, typically beyond three to five years, with risk rising the longer treatment continues. Warning signs often appear weeks or months in advance as a dull, aching pain in the groin, hip, or thigh that worsens with activity, and reporting this pain early allows for imaging before a complete break happens. Doctors may recommend a "drug holiday" after several years of treatment for people at lower risk, while those at high fracture risk often continue therapy because stopping raises the chance of hip and spine fractures. Several important factors affect your individual risk, including treatment duration, bone health, and other medications, so see below to understand more.

Last reviewed for medical accuracy: 08/18/2026

If you are experiencing thigh, hip, or groin pain and are unsure what it means, a free, instant symptom check can help you organize your symptoms and understand which next steps make sense. It takes only a few minutes, requires no sign-up, and gives you clearer language to bring to your doctor so nothing important gets overlooked. Early reporting of unexplained thigh pain is one of the few things known to prevent a partial stress fracture from becoming a complete break, which makes acting now gen

answer background

Explanation

Can Bisphosphonates Cause Thigh Bone Fractures?

Bisphosphonates are a common treatment for osteoporosis and other bone-weakening conditions. Over the last two decades, rare cases of atypical femoral (thigh bone) fractures have been reported in long-term users. This article reviews what is known from credible research, helping you weigh benefits and risks while staying informed and proactive about your bone health.


Understanding Bisphosphonates

Bisphosphonates include medications such as alendronate (Fosamax), risedronate (Actonel), ibandronate (Boniva) and zoledronic acid (Reclast). They:

  • Slow down bone breakdown by inhibiting osteoclasts, the cells that remove old bone.
  • Increase overall bone density and reduce common fracture risks (e.g., hip and spine).
  • Are usually prescribed in daily, weekly, monthly or yearly doses, depending on the specific drug.

Main benefits
• Proven to cut hip and spine fractures by 40–50% in postmenopausal osteoporosis.
• Often well-tolerated; serious side effects are uncommon.


How Bisphosphonates Work

  1. Bone remodeling balance
    • In healthy bone, osteoclasts remove old bone and osteoblasts form new bone.
    • Bisphosphonates “shift” this balance toward bone formation by suppressing osteoclasts.

  2. Mineralization improvement
    • By slowing bone turnover, bisphosphonates allow more complete mineralization, which strengthens bone structure.

  3. Long half-life
    • These drugs bind tightly to bone and can remain active for years after stopping therapy.


The Link Between Bisphosphonates and Atypical Thigh Bone Fractures

While bisphosphonates reduce common fracture types, “atypical femoral fractures” (AFFs) have emerged as a concern:

  • Definition: Low-energy fractures occurring in the femoral shaft (thigh bone), often with minimal or no trauma.
  • Presentation: They may start as a tiny stress fracture on the lateral (outer) side of the thigh bone and progress over months.
  • Incidence: Estimated at 3–50 cases per 100,000 person-years—significantly rarer than hip or spine fractures prevented by bisphosphonates.
  • Onset: Most reported after 5–10 years of continuous use, but cases have occurred sooner.

What Research Shows

  • A 2010 review in the Journal of Bone and Mineral Research noted a small but measurable increase in AFF risk the longer bisphosphonates are used.
  • A 2019 study in the New England Journal of Medicine found that stopping bisphosphonates after 5 years reduced AFF risk while maintaining protection against typical fractures.
  • Guidelines from the American Society for Bone and Mineral Research advocate periodic reassessment (“drug holiday”) after 3–5 years in low-to-moderate risk patients.

Identifying Atypical Femoral Fractures

Early recognition is key to preventing a complete fracture. Warning signs include:

  • Unusual thigh or groin pain (dull, aching, often bilateral).
  • Prodromal symptoms: Occur days to months before a complete break.
  • Radiographic features on X-ray or MRI:
    • Transverse (horizontal) fracture line.
    • Thickened cortex on the outer (lateral) side of the femur.
    • Minimal bone displacement at first.

If you experience persistent thigh or groin pain and you’ve been on bisphosphonates for several years, seek evaluation.


Risk Factors

Not everyone on bisphosphonates will develop an atypical thigh bone fracture. Factors that raise risk include:

Duration of therapy: More than 5 years carries higher risk.
Glucocorticoid use: Long-term steroids add to bone-weakening effects.
Rheumatoid arthritis: Chronic inflammation affects bone health.
Low body weight: Less cushioning around bones.
Vitamin D deficiency: Impairs bone mineralization.
Femoral geometry: Certain thigh bone shapes may predispose to stress fractures.


Monitoring and Prevention Strategies

You and your doctor can work together to keep your fracture risk as low as possible:

  1. Periodic risk reassessment

    • After 3–5 years of bisphosphonate therapy, evaluate bone density and overall fracture risk.
    • Consider a “drug holiday” for low-risk patients.
  2. Supplementation

    • Ensure adequate calcium (1,000–1,200 mg daily) and vitamin D (800–2,000 IU) intake.
    • Check blood levels of 25-hydroxyvitamin D; aim for ≥30 ng/mL.
  3. Lifestyle habits

    • Engage in weight-bearing exercise (walking, strength training).
    • Avoid smoking and limit alcohol to no more than one drink per day.
  4. Imaging follow-up

    • If thigh pain develops, get a femur X-ray or MRI to catch stress reactions early.
  5. Switching therapies

    • If a patient develops an AFF or is at very high fracture risk, alternatives include denosumab, teriparatide or raloxifene, based on individual factors.

What to Do If You Have Symptoms

If you’re on long-term bisphosphonates and notice thigh or groin pain:

  • Don’t ignore persistent or worsening discomfort.
  • Request imaging (X-ray or MRI) specifically looking for stress fractures.
  • Temporary discontinuation of bisphosphonates may be advised until findings are clear.
  • If a stress fracture is confirmed, protected weight-bearing (crutches or brace) and orthopedic referral are common next steps.

You might also consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to guide your next steps and questions for your healthcare provider. https://ubiehealth.com/


Balancing Benefits and Risks

Bisphosphonates dramatically lower the chance of common, high-risk fractures (hip, vertebral). Atypical thigh bone fractures remain very uncommon. Key takeaways:

  • Absolute risk of an AFF is low compared to fractures prevented.
  • Regular monitoring and following guidelines on treatment duration minimize risk.
  • Open communication with your doctor ensures therapy matches your changing risk profile.

Conclusion

Bisphosphonate-related atypical femoral fractures are rare but real. By understanding warning signs, reassessing long-term therapy and maintaining bone-healthy habits, you can safely benefit from these medications. If you experience unusual thigh or groin pain, seek prompt evaluation. For non-urgent guidance, try a free, online symptom check, using the doctor approved Ubie Symptom Checker.

Always speak to a doctor about anything that could be life-threatening or serious.

(References)

  • * Bisphosphonates: atypical fractures? Prescrire Int. 2009 Feb;18(99):25. PMID: 19396935.

  • * Compston JE. Bisphosphonates and atypical femoral fractures: a time for reflection. Maturitas. 2010 Jan;65(1):3-4. doi: 10.1016/j.maturitas.2009.11.002. Epub 2009 Nov 22. PMID: 19932574.

  • * Shane E, Burr D, Abrahamsen B, Adler RA, Brown TD, Cheung AM, Cosman F, Curtis JR, Dell R, Dempster DW, Ebeling PR, Einhorn TA, Genant HK, Geusens P, Klaushofer K, Lane JM, McKiernan F, McKinney R, Ng A, Nieves J, O'Keefe R, Papapoulos S, Howe TS, van der Meulen MC, Weinstein RS, Whyte MP. Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2014 Jan;29(1):1-23. doi: 10.1002/jbmr.1998. Epub 2013 Oct 1. PMID: 23712442.

  • * Tyler W, Bukata S, O'Keefe R. Atypical femur fractures. Clin Geriatr Med. 2014 May;30(2):349-59. doi: 10.1016/j.cger.2014.01.010. Epub 2014 Mar 4. PMID: 24721373.

  • * Adler RA, El-Hajj Fuleihan G, Bauer DC, Camacho PM, Clarke BL, Clines GA, Compston JE, Drake MT, Edwards BJ, Favus MJ, Greenspan SL, McKinney R Jr, Pignolo RJ, Sellmeyer DE. Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2016 Jan;31(1):16-35. doi: 10.1002/jbmr.2708. PMID: 26350171; PMCID: PMC4906542.

  • * Yano Y, Kuriyama A, Yano Y, Takeshita A, Hashizume H. Atypical femoral fracture with bisphosphonate use. QJM. 2020 Nov 1;113(11):825-826. doi: 10.1093/qjmed/hcaa073. PMID: 32091607.

  • * Black DM, Geiger EJ, Eastell R, Vittinghoff E, Li BH, Ryan DS, Dell RM, Adams AL. Atypical Femur Fracture Risk versus Fragility Fracture Prevention with Bisphosphonates. N Engl J Med. 2020 Aug 20;383(8):743-753. doi: 10.1056/NEJMoa1916525. PMID: 32813950; PMCID: PMC9632334.

  • * Lo JC, Grimsrud CD. Identifying Complete Atypical Femur Fractures in Adults with Bisphosphonate Exposure. Endocr Pract. 2024 Mar;30(3):278-281. doi: 10.1016/j.eprac.2023.12.012. Epub 2023 Dec 16. PMID: 38110088; PMCID: PMC10950361.

  • * Anderson PA, Kates SL, Watts NB. Update on Atypical Femoral Fractures. J Bone Joint Surg Am. 2024 Oct 2;106(19):1819-1828. doi: 10.2106/JBJS.23.01439. Epub 2024 Aug 22. PMID: 39172879.

  • * Alnajmi RAY, Ali DS, Khan AA. Diagnosis and Management of Atypical Femoral Fractures and Medication-Related Osteonecrosis of the Jaw in Patients with Osteoporosis. Endocrinol Metab Clin North Am. 2024 Dec;53(4):607-618. doi: 10.1016/j.ecl.2024.08.007. PMID: 39448140.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.